New glasses could slow Kids' worsening eyesight
NCT ID NCT06263946
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether Essilor Stellest spectacle lenses can slow the progression of myopia (nearsightedness) in children and teens aged 6 to 16. One hundred fifty participants will wear the lenses for at least 12 hours a day over 24 months. Researchers will measure changes in eye length and prescription strength to see if the lenses work better than expected natural progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Essilor Stellest spectacle lenses
What this could lead to
If successful, these lenses could offer a simple, non-invasive way to slow worsening nearsightedness in children, reducing the need for stronger prescriptions.
What could go wrong
This is a post-market study with no control group, so results may be less definitive. The lenses require full-time wear for 2 years, and not all children may see the same benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Eye Research Ireland (CERI) - TU DUBLIN
Dublin, D07 H6K8, Ireland
-
Erasmus Medical Center
Rotterdam, 3015, Netherlands
-
Hôpital Fondation Adolphe de Rothschild - Ophthalmology Department
Paris, 75019, France